Cargando…
Drug repurposing screens and synergistic drug‐combinations for infectious diseases
Infectious diseases account for nearly one fifth of the worldwide death toll every year. The continuous increase of drug‐resistant pathogens is a big challenge for treatment of infectious diseases. In addition, outbreaks of infections and new pathogens are potential threats to public health. Lack of...
Autores principales: | Zheng, Wei, Sun, Wei, Simeonov, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758396/ https://www.ncbi.nlm.nih.gov/pubmed/28685814 http://dx.doi.org/10.1111/bph.13895 |
Ejemplares similares
-
Modelling in infectious diseases: between haphazard and hazard
por: Neuberger, A., et al.
Publicado: (2013) -
The virtual heart as a platform for screening drug cardiotoxicity
por: Yuan, Yongfeng, et al.
Publicado: (2015) -
Web‐based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience
por: Paolotti, D., et al.
Publicado: (2013) -
Heuristics for designing user‐centric drug products: Lessons learned from Human Factors and Ergonomics
por: Feufel, Markus A., et al.
Publicado: (2020) -
Synergistic drug combinations and machine learning for drug repurposing in chordoma
por: Anderson, Edward, et al.
Publicado: (2020)